WallStSmart

NOV Inc. (NOV)vsUSA Compression Partners LP (USAC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

NOV Inc. generates 702% more annual revenue ($8.69B vs $1.08B). USAC leads profitability with a 11.9% profit margin vs 1.1%. USAC trades at a lower P/E of 27.3x. USAC earns a higher WallStSmart Score of 64/100 (C+).

NOV

Hold

47

out of 100

Grade: D+

Growth: 3.3Profit: 4.5Value: 4.3Quality: 6.5
Piotroski: 3/9Altman Z: 1.95

USAC

Buy

64

out of 100

Grade: C+

Growth: 9.3Profit: 8.0Value: 7.0Quality: 4.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for NOV.

USACUndervalued (+45.1%)

Margin of Safety

+45.1%

Fair Value

$49.24

Current Price

$27.85

$21.39 discount

UndervaluedFair: $49.24Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NOV1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

USAC4 strengths · Avg: 9.5/10
Return on EquityProfitability
40.8%10/10

Every $100 of equity generates 41 in profit

Revenue GrowthGrowth
35.1%10/10

Revenue surging 35.1% year-over-year

EPS GrowthGrowth
95.8%10/10

Earnings expanding 95.8% YoY

Operating MarginProfitability
28.6%8/10

Strong operational efficiency at 28.6%

Areas to Watch

NOV4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.954/10

Grey zone — moderate risk

Return on EquityProfitability
1.5%3/10

ROE of 1.5% — below average capital efficiency

Profit MarginProfitability
1.1%3/10

1.1% margin — thin

Operating MarginProfitability
2.3%3/10

Operating margin of 2.3%

USAC2 concerns · Avg: 2.5/10
P/E RatioValuation
27.3x4/10

Moderate valuation

Debt/EquityHealth
9.451/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : NOV

The strongest argument for NOV centers on Price/Book. PEG of 1.31 suggests the stock is reasonably priced for its growth.

Bull Case : USAC

The strongest argument for USAC centers on Return on Equity, Revenue Growth, EPS Growth. Revenue growth of 35.1% demonstrates continued momentum.

Bear Case : NOV

The primary concerns for NOV are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 84.5x leaves little room for execution misses. Thin 1.1% margins leave little buffer for downturns.

Bear Case : USAC

The primary concerns for USAC are P/E Ratio, Debt/Equity. Debt-to-equity of 9.45 is elevated, increasing financial risk.

Key Dynamics to Monitor

NOV profiles as a value stock while USAC is a growth play — different risk/reward profiles.

NOV carries more volatility with a beta of 0.91 — expect wider price swings.

USAC is growing revenue faster at 35.1% — sustainability is the question.

USAC generates stronger free cash flow (62M), providing more financial flexibility.

Bottom Line

USAC scores higher overall (64/100 vs 47/100) and 35.1% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

NOV Inc.

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

NOV Inc. is an American multinational corporation based in Houston, Texas. It is a leading worldwide provider of equipment and components used in oil and gas drilling and production operations, oilfield services, and supply chain integration services to the upstream oil and gas industry.

Visit Website →

USA Compression Partners LP

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

USA Compression Partners, LP, provides compression services under fixed-term contracts to oil companies and independent producers, processors, collectors and transporters of natural gas and crude oil. The company is headquartered in Austin, Texas.

Want to dig deeper into these stocks?